secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K
Filed at:   2024-08-01T23:59:59+00:00
Accession:  0001753926-24-001333
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipella raises $1.28M in registered direct offering of common stock and pre-funded warrants at $0.62/share
--------------------------------------------------------------------------------

- Total offering of 2,066,000 equity units (399K shares + 1,667K pre-funded warrants) at $0.62 per unit.
- Gross proceeds ~$1.28M closed August 1, 2024; net proceeds for working capital and general corporate purposes.
- H.C. Wainwright served as exclusive placement agent; receives 7.5% cash fee and 154,950 warrants exercisable at $0.775.
- Pre-funded warrants exercisable immediately at $0.001/share with 9.99% beneficial ownership blocker.
- Company agreed to 30-day lock-up on equity issuance and 1-year restriction on variable rate transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392624001333/0001753926-24-001333-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392624001333/g084368_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-24-001333

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer